The Mid-Cycle Transition Over the past month, we’ve taken a different path than most equity strategists. Rather than getting excited about the reopening, we are getting more concerned about (1) execution risk and (2) what’s already priced in.First, on the execution front, there’s growing evidence that supply remains a problem for many companies, just as demand is picking up. These…
Morgan Stanley: Sunday Start | What’s Next in Global Macro
A financial market resource for the every-day investor and trader.
-
Onward and Upward in 2020?
Seth Golden, , Research Reports, 0
Just 2 more trading days remain in 2019 and with that we are looking forward to the longest expansion...
-
Weekly State of the Market: Correction Continues, Future Forward Returns Improve
Seth Golden, , Research Reports, 0
Every time the market falls a little, we worry it’s going to fall a lot. ~Michael Batnick When it...
-
Rough Markets, Tough Crowd
Seth Golden, , Research Reports, 0
If you would like to watch this week’s video blog, please feel free to click the provided link! Have...
-
Not Out Of The Woods Yet
Seth Golden, , Research Reports, 0
The weekend is where many a discipline and devoted investor/portfolio manager spend most of their free time in the...
-
Merrill Lynch: Market Outlook
Seth Golden, , Research Reports, 0
Macro Strategy—Trends from around the world show supply chain bottlenecks have been holding back global growth to a degree...
-
Fundstrat: Risk On To 4,500
Seth Golden, , Research Reports, 0
STRATEGY: July/August “chop” morphing into full Missouri (aka “show me state”) –> tilting us further into “risk-on” view –>...
-
Bulls Charge Ahead of FOMC and FAANMG
Seth Golden, , Research Reports, 0
Another week has passed and another week has proven the longstanding trend of dip buying activity. This has been...
-
Weekly State Of The Market: It’s A Bull Fight
Seth Golden, , Research Reports, 0
“The greatest enemy of a good plan is the dream of a perfect plan. Stick to the good plan.”...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00